Amedeo Smart

Free Medical Literature Service

 

Amedeo

Otorhinolaryngology
  Free Subscription

Articles published in
Clin Exp Allergy
    February 2024
  1. SIMARD ML, Novak N, Drolet JP, Joly MC, et al
    Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study.
    Clin Exp Allergy. 2024;54:120-129.
    >> Share

    January 2024
  2. TAN S, Zhou S, Fan K, Jin L, et al
    Bulk and single-cell transcriptome sequencing reveal the metabolic feature in chronic rhinosinusitis with polyps.
    Clin Exp Allergy. 2024;54:67-70.
    >> Share

    December 2023
  3. VOGELBERG C, Klimek L, Kruppert S, Becker S, et al
    Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
    Clin Exp Allergy. 2023 Dec 26. doi: 10.1111/cea.14444.
    >> Share

  4. LEHTIMAKI J, Gupta S, Hjelmso M, Shah S, et al
    Fungi and bacteria in the beds of rural and urban infants correlate with later risk of atopic diseases.
    Clin Exp Allergy. 2023;53:1268-1278.
    >> Share

    November 2023
  5. WOLFF D, Drewitz KP, Ulrich A, Siegels D, et al
    Allergic diseases as risk factors for Long-COVID symptoms: Systematic review of prospective cohort studies.
    Clin Exp Allergy. 2023;53:1162-1176.
    >> Share

  6. BAUER RN, Xie Y, Beaudin S, Wiltshire L, et al
    Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
    Clin Exp Allergy. 2023;53:1187-1197.
    >> Share

    September 2023
  7. BUCHHEIT KM, Hacker J, Maurer R, McGill A, et al
    Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
    Clin Exp Allergy. 2023;53:974-977.
    >> Share

    August 2023
  8. AHLBECK L, Ahlberg E, Stuivers L, Bjorkander J, et al
    Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial.
    Clin Exp Allergy. 2023;53:809-820.
    >> Share

    July 2023
  9. MOITRA S, Mahesh PA, Moitra S
    Allergic rhinitis in India.
    Clin Exp Allergy. 2023;53:765-776.
    >> Share

  10. LAHA A, Moitra S, Podder S
    A review on aero-allergen induced allergy in India.
    Clin Exp Allergy. 2023;53:711-738.
    >> Share

    June 2023
  11. LEE Y, Kim C, Lee E, Lee HY, et al
    Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort.
    Clin Exp Allergy. 2023 Jun 18. doi: 10.1111/cea.14362.
    >> Share

  12. GOKTAS P, Can Bostan O, Gulseren D, Cakmak ME, et al
    Thermo-SPT: A new skin prick test evaluation framework based on low-cost, portable smartphone thermography.
    Clin Exp Allergy. 2023;53:626-635.
    >> Share

    April 2023
  13. DUAN S, Han X, Jiao J, Wang M, et al
    Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
    Clin Exp Allergy. 2023;53:443-454.
    >> Share

    March 2023
  14. MAHESH PA, Moitra S, Mabalirajan U, Garg M, et al
    Allergic diseases in India - Prevalence, risk factors and current challenges.
    Clin Exp Allergy. 2023;53:276-294.
    >> Share

    February 2023
  15. SOUZA DA CUNHA S, Santorelli G, Pembrey L
    Defining cases of asthma, eczema and allergic rhinitis using electronic health records in the Born in Bradford birth cohort.
    Clin Exp Allergy. 2023 Feb 9. doi: 10.1111/cea.14291.
    >> Share

    December 2022
  16. SHAMJI MH, Boyle RJ
    Mepolizumab for eosinophilic chronic rhinosinusitis, loss of smell and challenges with accessibility to allergen immunotherapy.
    Clin Exp Allergy. 2022;52:1358-1360.
    >> Share

  17. JIANG Z, Xiao H, Zhang H, Jia Q, et al
    Broussonetia papyrifera (paper mulberry) pollen is an important cause of allergic rhinitis in Southwest China.
    Clin Exp Allergy. 2022;52:1448-1451.
    >> Share

  18. VALBERT F, Neusser S, Pfaar O, Klimek L, et al
    Care with allergen immunotherapy for allergic respiratory diseases in Germany-Predictors and deficits.
    Clin Exp Allergy. 2022;52:1422-1431.
    >> Share

  19. TCHEKMEDYIAN R, Lundberg M, Buchheit KM, Maurer R, et al
    Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.
    Clin Exp Allergy. 2022;52:1414-1421.
    >> Share

  20. WALTER S, Ho J, Alvarado R, Smith G, et al
    Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis.
    Clin Exp Allergy. 2022;52:1403-1413.
    >> Share

    November 2022
  21. HWANG IC, Ahn HY
    Oxidative balance in subjects with allergic rhinitis: A nationwide cross-sectional survey.
    Clin Exp Allergy. 2022;52:1347-1350.
    >> Share

  22. ROLLEMA C, van Roon EN, van Boven JFM, Hagedoorn P, et al
    Pharmacology, particle deposition and drug administration techniques of intranasal corticosteroids for treating allergic rhinitis.
    Clin Exp Allergy. 2022;52:1247-1263.
    >> Share

  23. BIRS I, Boulay ME, Bertrand M, Cote A, et al
    Heterogeneity of asthma with nasal polyposis phenotypes: A cluster analysis.
    Clin Exp Allergy. 2022 Nov 1. doi: 10.1111/cea.14247.
    >> Share

    October 2022
  24. ANTO A, Sousa-Pinto B, Czarlewski W, Pfaar O, et al
    Automatic market research of mobile health apps for the self-management of allergic rhinitis.
    Clin Exp Allergy. 2022;52:1195-1207.
    >> Share

    September 2022
  25. SKYPALA IJ, Hunter H, Krishna MT, Rey-Garcia H, et al
    BSACI guideline for the diagnosis and management of pollen food syndrome in the UK.
    Clin Exp Allergy. 2022;52:1018-1034.
    >> Share

  26. PETERS AT, Soler ZM, Kern RC, Heffler E, et al
    Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
    Clin Exp Allergy. 2022;52:1105-1109.
    >> Share

  27. LOPEZ DJ, Lodge CJ, Bui DS, Waidyatillake NT, et al
    Establishing subclasses of childhood eczema, their risk factors and prognosis.
    Clin Exp Allergy. 2022;52:1079-1090.
    >> Share

    August 2022
  28. ERMIS SSO, Borres MP, Basna R, Ekerljung L, et al
    Sensitization to molecular dog allergens in an adult population: Results from the West Sweden Asthma Study.
    Clin Exp Allergy. 2022 Aug 19. doi: 10.1111/cea.14216.
    >> Share

  29. STOJANOVIC S, Zubrinich C, Sverrild A, Mahoney J, et al
    Laryngoscopy diagnosis of inducible laryngeal obstruction during supervised challenge for suspected anaphylaxis.
    Clin Exp Allergy. 2022;52:924-928.
    >> Share

  30. EIDE JG, Wu J, Stevens WW, Bai J, et al
    Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps.
    Clin Exp Allergy. 2022;52:954-964.
    >> Share

  31. SHOKOUHI SHOORMASTI R, Rafaiani C, Fazlollahi MR, Kazemnejad A, et al
    Molecular profile of specific IgE to allergenic components in allergic adults using allergen nano-bead array.
    Clin Exp Allergy. 2022;52:942-953.
    >> Share

    July 2022
  32. PRICE CPE, Guo A, Stevens WW, Cousens L, et al
    Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial.
    Clin Exp Allergy. 2022;52:859-867.
    >> Share

  33. GREGORY I, Grewal A
    Cochrane corner: Intranasal corticosteroids for non-allergic rhinitis.
    Clin Exp Allergy. 2022;52:836-838.
    >> Share

  34. BREW BK, Almqvist C, Lundholm C, Andreasson A, et al
    Comorbidity of atopic diseases and gastro-oesophageal reflux: evidence of a shared cause.
    Clin Exp Allergy. 2022;52:868-877.
    >> Share

  35. FENG M, Luo T, Xian M, Shi X, et al
    Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
    Clin Exp Allergy. 2022;52:878-887.
    >> Share

    June 2022
  36. AHLBECK L, Ahlberg E, Bjorkander J, Alden C, et al
    Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen.
    Clin Exp Allergy. 2022;52:747-759.
    >> Share

  37. MARTENSSON A, Nordstrom FU, Cervin-Hoberg C, Lindstedt M, et al
    Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial.
    Clin Exp Allergy. 2022;52:774-783.
    >> Share

    May 2022
  38. GILL AS, Alt JA, Pulsipher A, Smith KA, et al
    Topographic distribution of gene expression and sinonasal inflammation in chronic rhinosinusitis without nasal polyposis.
    Clin Exp Allergy. 2022;52:719-722.
    >> Share

  39. MATUCCI A, Nencini F, Maggiore G, Chiccoli F, et al
    High proportion of inflammatory CD62L(low) eosinophils in blood and nasal polyps of severe asthma patients.
    Clin Exp Allergy. 2022 May 1. doi: 10.1111/cea.14153.
    >> Share

    April 2022
  40. SUBIZA J, Cabrera M, Jm CR, Jc C, et al
    Influence of climate change on airborne pollen concentrations in Madrid, 1979-2018.
    Clin Exp Allergy. 2022;52:574-577.
    >> Share

    March 2022
  41. MAHONEY J, Hew M, Vertigan A, Oates J, et al
    Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review.
    Clin Exp Allergy. 2022;52:387-404.
    >> Share

    February 2022
  42. BACHERT C, Peters AT, Heffler E, Han JK, et al
    Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 stud
    Clin Exp Allergy. 2022;52:244-249.
    >> Share

  43. YAO Y, Zeng M, Liu Z
    Revisiting Asian chronic rhinosinusitis in the era of type 2 biologics.
    Clin Exp Allergy. 2022;52:231-243.
    >> Share

    January 2022
  44. SIO YY, Shi P, Say YH, Chew FT, et al
    Functional variants in the chromosome 4q21 locus contribute to allergic rhinitis risk by modulating the expression of N-acylethanolamine acid amidase.
    Clin Exp Allergy. 2022;52:127-136.
    >> Share

    December 2021
  45. SCALA E, Caprini E, Abeni D, Meneguzzi G, et al
    A qualitative and quantitative comparison of IgE antibody profiles with two multiplex platforms for component-resolved diagnostics in allergic patients.
    Clin Exp Allergy. 2021;51:1603-1612.
    >> Share

  46. JAKWERTH CA, Chaker AM, Guerth F, Oelsner M, et al
    Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapy.
    Clin Exp Allergy. 2021;51:1577-1591.
    >> Share

    August 2021
  47. MACGLASHAN D JR, Alvarez-Arango S, Tversky J
    Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels.
    Clin Exp Allergy. 2021;51:1093-1095.
    >> Share

  48. SOARES P, Fidler K, Felton J, Jones CJ, et al
    An FCER2 polymorphism is associated with increased oral leukotriene receptor antagonists and allergic rhinitis prescribing.
    Clin Exp Allergy. 2021;51:1089-1092.
    >> Share

  49. LAM HCY, Jarvis D
    Seasonal variation in total and pollen-specific immunoglobulin E levels in the European Community Respiratory Health Survey.
    Clin Exp Allergy. 2021;51:1085-1088.
    >> Share

  50. BOUSQUET J, Schroder-Bernhardi D, Bachert C, Canonica GW, et al
    Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms.
    Clin Exp Allergy. 2021;51:1033-1045.
    >> Share

    July 2021
  51. RAMPERSAD A, Banerjee N, Hinks TSC
    Are biologics for chronic rhinosinusitis effective and safe?
    Clin Exp Allergy. 2021;51:870-872.
    >> Share

    June 2021
  52. MARGARITTE-JEANNIN P, Budu-Aggrey A, Ege M, Madore AM, et al
    Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.
    Clin Exp Allergy. 2021 Jun 22. doi: 10.1111/cea.13972.
    >> Share

  53. ARASI S, Castelli S, Di Fraia M, Villalta D, et al
    @IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis.
    Clin Exp Allergy. 2021;51:821-828.
    >> Share

  54. TVERSKY J, Lane AP, Azar A
    Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.
    Clin Exp Allergy. 2021;51:836-844.
    >> Share

  55. BALLARDINI N, Bergstrom A, Kull I, Almqvist C, et al
    Resolved allergen-specific IgE sensitization among females and early poly-sensitization among males impact IgE sensitization up to age 24 years.
    Clin Exp Allergy. 2021;51:849-852.
    >> Share

  56. WRAITH DC, Krishna MT
    Peptide allergen-specific immunotherapy for allergic airway diseases-State of the art.
    Clin Exp Allergy. 2021;51:751-769.
    >> Share

  57. HACCURIA A, Van Muylem A, Malinovschi A, Rasschaert J, et al
    Increased expression of IL-33 is found in the lower airways of patients with seasonal allergic rhinitis and is not related to natural allergen exposure.
    Clin Exp Allergy. 2021;51:845-848.
    >> Share

    May 2021
  58. BOYLE RJ, Shamji MH
    What does it mean to be food allergic?
    Clin Exp Allergy. 2021;51:634-635.
    >> Share

  59. IDROSE NS, Walters EH, Zhang J, Vicendese D, et al
    Outdoor pollen-related changes in lung function and markers of airway inflammation: A systematic review and meta-analysis.
    Clin Exp Allergy. 2021;51:636-653.
    >> Share

    April 2021
  60. MATTSSON L, Valcour A, Holmqvist M, Larsson H, et al
    Cyclophilin - A novel cross-reactive determinant in peanut.
    Clin Exp Allergy. 2021;51:620-622.
    >> Share

  61. POTAPOVA E, Bauersachs D, Villella V, Meneguzzi G, et al
    Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients.
    Clin Exp Allergy. 2021;51:604-613.
    >> Share

    March 2021
  62. LOO EXL, Liew TM, Yap GC, Wong LSY, et al
    Trajectories of early-onset rhinitis in the Singapore GUSTO mother-offspring cohort.
    Clin Exp Allergy. 2021;51:419-429.
    >> Share

    February 2021
  63. SHAMJI MH, Boyle RJ
    What does climate change mean for people with pollen allergy?
    Clin Exp Allergy. 2021;51:202-205.
    >> Share

  64. AIROUCHE S, Beltrami V, Fleury S, Batard T, et al
    Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
    Clin Exp Allergy. 2021;51:339-349.
    >> Share

  65. WURTZEN PA, Gronager PM, Lund G, Gupta S, et al
    Simplified AIT for allergy to several tree pollens-Arguments from the immune outcome analyses following treatment with SQ tree SLIT-tablet.
    Clin Exp Allergy. 2021;51:284-295.
    >> Share

  66. ORBAN NT, Jacobson MR, Nouri-Aria KT, Durham SR, et al
    Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2-type inflammation but no evidence of remodelling.
    Clin Exp Allergy. 2021;51:329-338.
    >> Share

    January 2021
  67. MPAIRWE H, Nkurunungi G, Tumwesige P, Akurut H, et al
    Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda.
    Clin Exp Allergy. 2021;51:108-119.
    >> Share

  68. MARTENS K, Seys SF, Alpizar YA, Schrijvers R, et al
    Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity.
    Clin Exp Allergy. 2021;51:87-98.
    >> Share

  69. FENG Q, Bonnelykke K, Ek WE, Chawes BL, et al
    Null association between serum 25-hydroxyvitamin D levels with allergic rhinitis, allergic sensitization and non-allergic rhinitis: A Mendelian randomization study.
    Clin Exp Allergy. 2021;51:78-86.
    >> Share

  70. SUBRAMANIAN A, Adderley NJ, Gkoutos GV, Gokhale KM, et al
    Ethnicity-based differences in the incident risk of allergic diseases and autoimmune disorders: A UK-based retrospective cohort study of 4.4 million participants.
    Clin Exp Allergy. 2021;51:144-147.
    >> Share

    October 2020
  71. CECCHI L, Scala E, Caronni S, Citterio S, et al
    Allergenicity at component level of subpollens particles from different sources obtained by osmolar shock: a molecular approach to thunderstorm-related asthma outbreaks.
    Clin Exp Allergy. 2020 Oct 18. doi: 10.1111/cea.13764.
    >> Share

  72. BLONDAL V, Malinovschi A, Sundbom F, James A, et al
    Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA(2) LEN study.
    Clin Exp Allergy. 2020 Oct 14. doi: 10.1111/cea.13759.
    >> Share

  73. CONLAN N, Maher GM, Al Khalaf SY, McCarthy FP, et al
    Association between Hypertensive Disorders of Pregnancy and the Risk of Asthma, Eczema and Allergies in Offspring: A Systematic Review and Meta-analysis.
    Clin Exp Allergy. 2020 Oct 9. doi: 10.1111/cea.13754.
    >> Share

    September 2020
  74. DU K, Zheng M, Zhao Y, Xu W, et al
    Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps.
    Clin Exp Allergy. 2020 Sep 28. doi: 10.1111/cea.13747.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016